Terapi Radiasi untuk Sarkoma di Israel — dapatkan 3 kecocokan klinik pribadi

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – seorang pelopor dalam pengobatan sarkoma dengan lebih dari 25 tahun keahlian terfokus.

• Menjalani pelatihan fellowship di Institut Gustave Roussy di Paris – pusat sarkoma terkemuka di Eropa
• Anggota Fakultas ESMO untuk sarkoma – membantu membentuk pedoman pengobatan internasional
• Telah memublikasikan secara ekstensif tentang terapi dan hasil sarkoma
• Menggabungkan onkologi radiasi dengan pendekatan pengobatan sistemik

Dr. Dror Levin berspesialisasi dalam pengobatan sarkoma pediatrik di Sourasky Medical Center – salah satu rumah sakit terkemuka di Israel untuk kanker anak.

• Direktur hematologi onkologi pediatrik di Sourasky
• Mendapatkan pelatihan di Rizzoli Orthopaedic Institute – pemimpin dunia dalam perawatan sarkoma
• Mengoordinasikan pengobatan sarkoma dengan tim onkologi ortopedi
• Anggota asosiasi hemato-onkologi pediatrik Israel (ISPHO)

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.